Skip to content

Clinical trials

Terminated Myeloproliferative Disorders trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Terminated Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20101
20121
20131
20141
20151
20161
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Ariad Pharmaceuticals2
CTI BioPharma2
European Organisation for Research and Treatment of Cancer - EORTC1
Kiadis Pharma1
University of Liege1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders10
Primary Myelofibrosis6
Bone Marrow Diseases4
Hematologic Diseases4
Leukemia4
Multiple Myeloma4
Myelodysplastic Syndromes4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid3
Lymphoma3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.